About: Cleo Diagnostics Ltd, a biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: A$0.30 (-3.28%)
COV ASX Cleo Diagnostics Ltd
Cleo Diagnostics Ltd share price
Atividade de preço de COV
Último preço
$ 0,300
Variação (24h)
-0,01 AUD (3,28%)
Volume
47.54K
Volume (média 4 sem.)
-
Abertura
$ 0,31
Variação do dia
$ 0,30 - $ 0,31
Fechamento anterior
$ 0,31
Último negócio
27 Oct, 4:12 am GMT+0
Atrasado
27 Oct, 4:12 am GMT+0
COV price performance
Atrasado
27 Oct, 4:12 am GMT+0
quote.marketSignals